Saturday, September 5, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· February 23, 2026

Top Wide-Moat Stocks to Invest in for Long-term Growth

View original at finance.yahoo.com
Top Wide-Moat Stocks to Invest in for Long-term Growth An updated edition of the January 5, 2026 article. A wide moat refers to companies with lasting competitive advantages that protect them from rivals, similar to how a moat defends a castle…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The generative AI revolution continues to be a tailwind for NVIDIA

    80% confidence
  • Datacenter presents a solid growth opportunity for NVIDIA as businesses are increasingly shifting toward cloud

    80% confidence
  • Lam Research has high exposure to the memory segment, which is likely to see tremendous growth in the long run

    80% confidence
  • Moody's dominant position in the credit rating industry, along with opportunistic acquisitions and restructuring efforts to diversify revenues and footprint, supports top-line expansion

    80% confidence
  • NVIDIA is rapidly gaining traction in enterprise AI, expanding its market beyond cloud providers

    80% confidence
  • Technology inflections in the semiconductor industry, including 3D device scaling, multiple patterning, process flow, and advanced packaging chip integration, are expected to continue driving sustainable growth and increasing Lam Research's served market

    80% confidence
  • ASML is well-positioned to capitalize on the AI revolution, which is driving massive demand for advanced semiconductors

    80% confidence
  • With AI applications requiring more efficient and high-speed memory, high-bandwidth memory adoption is accelerating

    80% confidence
  • ASML's High-NA EUV technology represents the next frontier in chip manufacturing designed for sub-2nm nodes

    80% confidence
  • AI adoption is spreading beyond cloud hyperscalers, with industries such as healthcare, automotive, and robotics increasingly investing in AI-powered solutions

    80% confidence
  • ASML maintains a near-monopoly on extreme ultraviolet (EUV) lithography, which is essential for producing advanced chips at 3nm and below

    80% confidence
  • Wide-moat companies typically derive their advantage from factors such as strong brand recognition, network effects, high customer switching costs, regulatory hurdles and economies of scale

    80% confidence
  • Lam Research is at the center of the AI revolution, with its advanced fabrication tools playing a crucial role in enabling high-performance computing

    80% confidence
  • Investing in wide-moat companies provides a solid strategy for building long-term wealth, as these businesses typically produce steady cash flows and deliver shareholder value through dividend payments and stock price growth

    80% confidence
  • The semiconductor memory market is being driven by the growing proliferation of artificial intelligence (AI), Machine Learning, Blockchain, cloud computing, big data, mobile devices and the Internet of Things

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com